Anhui Construction Engineering Co., Ltd.: A major project that won the bid of 15.506 billion yuan was announced by Anhui Construction Engineering Co., Ltd., and the company and its subsidiaries recently received the notice of winning the bid. The winning project is the Yangtze River Bridge and wiring project of Taishan Road in Wuhu, S24 Hanghe Expressway. The project is located in Wuhu City, and its main contents include investment, financing, survey and design, construction, operation management, maintenance, debt repayment and handover, with a total investment of about 15.506 billion yuan. The construction period of the project is 48 months and the charging period is 356 months. This project was jointly won by a consortium composed of several companies, such as CCCC Second Waterway Engineering Bureau Co., Ltd.. Putin had a phone conversation with Hungarian President Orban on the situation in Ukraine. According to the Tass news agency, Russian President Vladimir Putin and Hungarian Prime Minister Orban discussed the further development of energy projects.
South Korean Finance Minister and US Treasury Secretary Yellen confirmed that they will work closely together.Putin had a phone conversation with Hungarian President Orban on the situation in Ukraine. According to the Tass news agency, Russian President Vladimir Putin and Hungarian Prime Minister Orban discussed the further development of energy projects.Goldman Sachs: I don't agree that gold can't reach $3,000 under a strong dollar. Goldman Sachs said that we don't agree with the view that the price of gold can't rise to $3,000 per ounce by the end of 2025 when the dollar remains strong for a long time. We predict that gold will reach $3,000 per ounce by the end of 2025, and the reduction of interest rate cuts by the Federal Reserve (rather than the strengthening of the US dollar) is the downside risk of this prediction.
Hengrui Pharma: HRS-4729 injection was approved for clinical trial. Hengrui Pharma announced that the company and its subsidiary Fujian Sheng Di Pharmaceutical Co., Ltd. received the Notice of Approval for Clinical Trial of HRS-4729 injection approved and issued by National Medical Products Administration. The drug is a polypeptide drug independently developed, and it is a GLP-1R/GIPR/GCGR triple agonist, which is suitable for obese or overweight patients. Up to now, HRS-4729 injection has invested about 19.56 million yuan in research and development.General Motors (GM): The unmanned business Cruise and GM Technical team will be merged, and the plan is expected to be completed in the first half of 2025. According to the priority of GM's capital allocation, GM will no longer fund Cruise's self-driving taxi development business.Nine associations, including China Consumers Association and internet society of china, China Hotel Association, China Self-employed Workers Association, china electronic chamber of commerce, China Packaging Federation, China Chain Store & Franchise Association, China Baked Food and Sugar Products Industry Association and China Nutrition Society, jointly proposed on December 11 to encourage catering industry operators (including self-employed workers) to curb catering waste in the industry through innovative measures, public welfare publicity and optimized services.
Strategy guide 12-14
Strategy guide
12-14
Strategy guide
Strategy guide 12-14
Strategy guide
12-14
Strategy guide 12-14
Strategy guide 12-14